Deferred Tax Assets, Gross of VERTEX PHARMACEUTICALS INC / MA from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • VERTEX PHARMACEUTICALS INC / MA Deferred Tax Assets, Gross for the quarter ending 31 Dec 2025 was $3,723,900,000, a 18% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $3,723,900,000 +$562,500,000 +18% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q4 2024 $3,161,400,000 +$726,600,000 +30% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q4 2023 $2,434,800,000 +$589,500,000 +32% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $1,845,300,000 +$364,100,000 +25% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 $1,481,200,000 +$84,700,000 +6.1% 31 Dec 2021 10-K 10 Feb 2023 2022 FY
Q4 2020 $1,396,500,000 -$229,858,000 -14% 31 Dec 2020 10-K 09 Feb 2022 2021 FY
Q4 2019 $1,626,358,000 -$253,767,000 -13% 31 Dec 2019 10-K 11 Feb 2021 2020 FY
Q4 2018 $1,880,125,000 +$145,583,000 +8.4% 31 Dec 2018 10-K 13 Feb 2020 2019 FY
Q4 2017 $1,734,542,000 -$247,393,000 -12% 31 Dec 2017 10-K 13 Feb 2019 2018 FY
Q4 2016 $1,981,935,000 +$88,719,000 +4.7% 31 Dec 2016 10-K 15 Feb 2018 2017 FY
Q4 2015 $1,893,216,000 +$324,286,000 +21% 31 Dec 2015 10-K 23 Feb 2017 2016 FY
Q4 2014 $1,568,930,000 +$191,167,000 +14% 31 Dec 2014 10-K 16 Feb 2016 2015 FY
Q4 2013 $1,377,763,000 +$165,593,000 +14% 31 Dec 2013 10-K 13 Feb 2015 2014 FY
Q4 2012 $1,212,170,000 -$117,835,000 -8.9% 31 Dec 2012 10-K 11 Feb 2014 2013 FY
Q4 2011 $1,330,005,000 -$38,128,000 -2.8% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q4 2010 $1,368,133,000 31 Dec 2010 10-K 22 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.